SLC5A2 and diabetic ketoacidosis: However, SGLT-2 inhibitors were associated with an increased risk of diabetic ketoacidosis (RR 2.59 CI95% 1.57, 4.27) and genital infections (RR 3.50 CI95% 3.09, 3.95) (17).